Archives

• 2019
• |
• 2018
• |
• 2017
• |
• 2016
• |
• 2015
• |
• 2014
• |
• 2013
• |
• 2012

Conference Reports

2018

Sunday, February 25, 2018

ACC Rockies Founders Lecture:
Reflections on Balancing Precision and Personalized Cardiovascular Medicine

Paul W. Armstrong

Re-Setting our COMPASS for Secondary Prevention in Atherosclerotic Vascular Disease

Robert Welsh

Updates from the 2017 Canadian Cardiovascular Society Antiplatelet Therapy Guidelines

Simon Robinson

Evidence Based Anti-thrombotic Management of the Overlap Patient With Both Atrial Fibrillation and an Acute Coronary Syndrome/PCI

Kevin Bainey

Contemporary Approaches to Secondary Prevention in the High-Risk Diabetes Patient

Shaun Goodman

Monday, February 26, 2018

HFpEF: Is the ‘P’ for Promise or Pessimism?

Justin Ezekowitz

Natriuretic Peptides: Golden Child or Fool’s Gold?

Justin Ezekowitz

Advances in the Management of Acute and Chronic Aortic Disease

Paul Fedak

Venous Thromboembolism Management in 2018

Deepa Suryanarayan

Left Atrial Occlusion – Defining Obstacles and Opportunities With Clinical Application

Carlos Morillo

Contemporary Management of Functional Mitral Regurgitation

Paul Fedak

Percutaneous Management of Aortic Valve Stenosis - TAVI Update

Alexander Dick

Contemporary Secondary Prevention – How, When and In Whom Shall We Apply Novel Lipid, Anti-inflammatory or Anti-thrombotic Therapies? Applying the Canadian Cardiovascular Society Guidelines

Todd Anderson,

Jacques Genest

Tuesday, February 27, 2018

Applying Syncope Guidelines to Clinical Practice

Roopinder Sandhu

ICD Guidelines

Matthew Bennett

Atrial Fibrillation Ablation – Building a New CASTLE

Stephen Wilton

Approaches to Pacing in Complex Patient Populations

Jacques Rizkallah

The Role of Inflammation in CAD and Its Contemporary Management

Jacques Genest

Influenza and Cardiovascular Disease

Jacob Udell

Dyslipidemia Management in the Contemporary Era

Todd Anderson

Advances in Cardiac MR

Alexander Dick

Diabetes Management Symposium

Shaun Goodman,

& Michael Heffernan

Wednesday, February 28, 2018

Socioeconomic Impact of Novel Therapeutics on CVD Incidence and Outcomes

Todd Anderson

Evidence Based Imaging – An Elusive Goal

Paolo Raggi

Clinical Implications of Canada’s Regulatory Process for Approval of Generic Drugs

Fakhreddin Jamali